These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6033897)

  • 1. Endometrial and safety studies during quinestrol therapy.
    Cohen MR; Hankin H
    Int J Fertil; 1967; 12(2):203-9. PubMed ID: 6033897
    [No Abstract]   [Full Text] [Related]  

  • 2. Endometrial studies following quinestrol administration.
    Greenblatt RB; Zarate A
    Int J Fertil; 1967; 12(2):187-202. PubMed ID: 6033896
    [No Abstract]   [Full Text] [Related]  

  • 3. Endometrial morphology following oral administration of quinestrol.
    Ober WB; Bronstein SB
    Int J Fertil; 1967; 12(2):210-28. PubMed ID: 6033898
    [No Abstract]   [Full Text] [Related]  

  • 4. Quinestrol in the monopause.
    Zarate A; Greenblatt RB
    Int J Fertil; 1967; 12(2):233-4. PubMed ID: 6033900
    [No Abstract]   [Full Text] [Related]  

  • 5. Interrupted quinestrol therapy for inhibition of ovulation: efficacy, duration, and side effects.
    Skerlavay M; Epstein JA
    Int J Fertil; 1967; 12(2):247-50. PubMed ID: 6033904
    [No Abstract]   [Full Text] [Related]  

  • 6. Quinestrol therapy in the menopausal patient.
    Hankin H
    Int J Fertil; 1967; 12(2):229-32. PubMed ID: 6033899
    [No Abstract]   [Full Text] [Related]  

  • 7. Endometrial histology following 1 year of a continuous daily regimen of levonorgestrel 90 micro g/ethinyl estradiol 20 micro g.
    Johnson JV; Grubb GS; Constantine GD
    Contraception; 2007 Jan; 75(1):23-6. PubMed ID: 17161119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinestrol therapy in functional infertility.
    Cohen MR
    Int J Fertil; 1967; 12(2):255-60. PubMed ID: 6033905
    [No Abstract]   [Full Text] [Related]  

  • 9. Double blind intensive safety and tolerance studies during quinestrol therapy in elderly women.
    Cohen A
    Int J Fertil; 1967; 12(2):266-70. PubMed ID: 5340518
    [No Abstract]   [Full Text] [Related]  

  • 10. [On estrogen therapy of the climacteric syndrome].
    Mehring W; Heinen G
    Med Klin; 1968 Aug; 63(35):1385-8 passim. PubMed ID: 5682034
    [No Abstract]   [Full Text] [Related]  

  • 11. Quinestrol and the menopausal syndrome.
    Sands RX
    Int J Fertil; 1967; 12(2):235-8. PubMed ID: 6033901
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sequential triphasic therapy in the menopause].
    Samaja BA
    Ann Ostet Ginecol Med Perinat; 1969 Mar; 91(3):182-96. PubMed ID: 5362492
    [No Abstract]   [Full Text] [Related]  

  • 13. Double blind placebo controlled efficacy and safety study with quinestrol.
    Bronstein SB; Stough A; Long IR
    Int J Fertil; 1967; 12(2):274-81. PubMed ID: 5340519
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of quinestrol on ovulation.
    Greenblatt RB; Zarate A
    Int J Fertil; 1967; 12(2):243-6. PubMed ID: 6033903
    [No Abstract]   [Full Text] [Related]  

  • 15. [The endometrium under the effects of hormone replacement therapy in menopause with percutaneous estradiol and low-dose micronized progesterone].
    Philippe E; Faguer B; Engelman A; Charpin C; Loubière R; de Mascarel A; Leduc F; Dupin P; Hemet J; Vauzelle JL
    Pathologica; 1993; 85(1099):475-87. PubMed ID: 8127629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged menstrual response of patients with gonadal failure following quinestrol administration.
    Epstein JA
    Int J Fertil; 1967; 12(2):181-6. PubMed ID: 6033895
    [No Abstract]   [Full Text] [Related]  

  • 17. Full replacement therapy of the menopause.
    Scott MM
    Nebr Med J; 1972 Jan; 57(1):16-21. PubMed ID: 5008871
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacological treatment of the menopause. Clinical experiences].
    Tropea PF; Privitera S
    Minerva Ginecol; 1974 Jun; 26(6):367-74. PubMed ID: 4846850
    [No Abstract]   [Full Text] [Related]  

  • 19. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactation inhibition with quinestrol.
    Morris JA
    Int J Fertil; 1967; 12(2):261-5. PubMed ID: 5340517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.